Drug Delivery Technologies Market Report - Global Forecasts To 2017
DUBLIN, June 20, 2013 /PRNewswire/ --
Research and Markets (http://www.researchandmarkets.com/research/ppxhpn/drug_delivery) has announced the addition of the "Drug Delivery Technologies Market (Metered Dose Inhalers, Needle-Free Injectors, Auto-Injectors, Nasal Sprays, Transdermal Patches, Nebulizers, Infusion Pumps, Drug Eluting Stents, Sustained Release, Ocular Implants) - Global Forecasts To 2017" report to their offering.
(Logo: http://photos.prnewswire.com/prnh/20130307/600769 )
The drug delivery technology market is segmented on the basis of route of administration into nine categories - oral, pulmonary, transdermal, injectable, ocular, nasal, topical, implantable, and transmucosal drug delivery; the market is forecast till 2017. Over the years, drug delivery technologies have grown phenomenally from plain drug reformulation and release technologies to innovative platforms that hold a huge potential for the effective delivery of biologicals and novel drugs.
The global drug delivery market was worth $142.5 billion in the year 2012. Patent expiries of certain blockbuster drugs, growing demand for self-administration and home healthcare devices, rising incidence of chronic diseases such as cardiovascular diseases, diabetes and cancer, growing focus on pediatric and geriatric patients, and advancing technology are accelerating the growth of this market. However, drug failures and recalls, and technical barriers will hamper the growth of this market, to a certain extent.
Strategic collaborations, self-administration and home care drug delivery devices, and expanding applications of drug delivery into niche therapeutic areas represent vast opportunities for key players in this market. The growing number of elderly persons is a large consumer of home care drug delivery devices. The global ageing population (above 60 years) is set to increase from 784 million in 2011 to 2 billion by 2050 and 2.8 billion by 2100. (Source: UN Population Division). An increase in the number of geriatric patients and rise in demand for convenient drug delivery options pose major opportunities for the development of innovative and easy-to-use drug delivery systems.
This research report categorizes the global drug delivery market into oral, pulmonary, transdermal, injectable, ocular, nasal, topical, implantable, and transmucosal drug delivery. These markets are broken down into segments and sub-segments, providing exhaustive value analysis for 2010, 2011 and 2012, as well as forecast up to 2017. Each of the drug delivery market is comprehensively analyzed at a granular level by geography (North America, Europe, Asia, and Rest of the World) to provide in-depth information on the global scenario.
Key Topics Covered:
2 Executive Summary
3 Market Overview
4 Global Drug Delivery Market, By Technology
5 Geographic Analysis
6 Competitive Landscape
7 Company Profiles
- 3M Company
- Alkermes, Inc.
- Aptalis Pharma, Inc.
- Baxter International, Inc.
- Becton, Dickinson And Company
- Catalent Pharma Solutions
- Cima Labs
- Dali Medical Devices
- Endo Health Solutions, Inc.
- Johnson & Johnson, Inc.
- Nektar Therapeutics, Inc.
- Optinose As
- Psivida Corporation
- Skyepharma Plc
- The Dow Chemical Company
- Valeant Pharmaceuticals
- Ypsomed Holding Ag
For more information visit http://www.researchandmarkets.com/research/ppxhpn/drug_delivery
About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
SOURCE Research and Markets